The global cell counting market grew at a CAGR of around 6% during 2015-2020.
Looking forward, the analyst expects the market to exhibit moderate growth during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Cell counting refers to a technique used for the analysis of the cells or micelles that are usually suspended in blood or other body fluids. Some of the common instruments used for cell counting includes hemocytometers, spectrophotometers, flow cytometers, automated cell counters, etc. Cell counting aids in classifying cell types and detecting disease through probes to develop the best treatment plan for the patient. It also helps in understanding the structure and composition of the cells for chromosome analysis, protein expression, cancer diagnosis, hematological malignancies, etc. As a result, cell counting is extensively used across hospitals, diagnostic laboratories, research and academic institutes, pharmaceutical and biotechnology companies, etc.
The rising prevalence of various chronic ailments, such as cancer, HIV-AIDS, leukemia, Alzheimer’s, etc., is propelling the demand for cell counting techniques. Moreover, the growing adoption of cell counting instruments across diverse medical fields, such as molecular biology, immunology, pathology, etc., for developing next-generation therapeutics is also augmenting the market growth. In addition to this, the increasing utilization of cell counting for the identification and determination of primary tumor, circulating tumor, and metastatic tumor is further bolstering the market growth. Additionally, the widespread adoption of stem cell therapy is also propelling the demand for various cell counting instruments on a global level. In line with this, the rising awareness towards numerous benefits of cell counting technique in immunophenotyping, cell sorting, cell proliferation assays and intracellular calcium flux is further driving the market growth. Moreover, the increasing investments by several government bodies in extensive R&D activities pertaining to the fields of biotechnology, oncology stem cell therapeutics, etc., are also bolstering the adoption of cell counting techniques. In the coming years, the introduction of automated product variants with enhanced ability to process larger sample sizes at a higher speed will continue to drive the global market for cell counting.
Key Market Segmentation: the analyst provides an analysis of the key trends in each sub-segment of the global cell counting market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on product type and end-user.
Breakup by End User: Hospitals and Diagnostic Laboratories Research and Academic Institutes Pharmaceutical and Biotechnology Companies Others
Breakup by Region: North America United States Canada Asia Pacific China Japan India South Korea Australia Indonesia Others Europe Germany France United Kingdom Italy Spain Russia Others Latin America Brazil Mexico Others Middle East and Africa
Competitive Landscape: The competitive landscape of the industry has also been examined with some of the key players being Agilent Technologies Inc., Becton, Dickinson and Company, Bio-Rad Laboratories Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd. (Roche Holding AG)., Merck & Co. Inc., PerkinElmer Inc. and Thermo Fisher Scientific Inc. Key Questions Answered in This Report: How has the global cell counting market performed so far and how will it perform in the coming years? What are the key regional markets? What is the impact of COVID-19 on the global cell counting market? What is the breakup of the market based on the product type? What is the breakup of the market based on the end user? What are the various stages in the value chain of the industry? What are the key driving factors and challenges in the market? What is the structure of the global cell counting market and who are the key players? What is the degree of competition in the market?
Our reports have been used by over 10K customers, including:
In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global Labware Market Report The development of the laboratory glassware market is linked with the growth of industries like petrochemicals, polymer chemistry, and pharmaceuticals. Numerous manufacturers of laboratory glassware majorly rely on exports...
Global Oncology Precision Medicine Market to Reach $1,28,891.6 Million by 2031 Market Report Coverage - Oncology Precision Medicine Market Segmentation • Ecosystem - Precision Therapeutics, Applied Sciences, Digital Health and Information Technology, Precision Diagnostics • Application...
Global Capillary Electrophoresis Market to Reach $586.9 Million by 2031 Market Report Coverage - Capillary Electrophoresis Market Segmentation • By Product Type - Instrument, Consumables, and Software • By Mode - Capillary Gel Electrophoresis (CGE), Capillary Zone Electrophoresis (CZE),...
The Global Aptamers Market size is expected to reach $392.7 million by 2027, rising at a market growth of 17.6% CAGR during the forecast period. Aptamers are oligonucleotides, such as ribonucleic acid (RNA), single-strand deoxyribonucleic acid (ssDNA), or peptide molecules, having particular three-dimensional architectures that allow...
120 pages •
By Infiniti Research Limited
• Dec 2021
Global Aptamers Market 2022-2026 The analyst has been monitoring the aptamers market and it is poised to grow by $ 1.31 bn during 2022-2026, progressing at a CAGR of 27.70% during the forecast period. Our report on the aptamers market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges,...
120 pages •
By Infiniti Research Limited
• Mar 2022
Global Arbovirus Testing Market 2022-2026 The analyst has been monitoring the arbovirus testing market and it is poised to grow by $ 320.5 mn during 2022-2026 progressing at a CAGR of 5.6% during the forecast period. Our report on the arbovirus testing market provides a holistic analysis, market size and forecast, trends,...
The Global Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2015-2022 report provides comprehensive understanding and unprecedented access to the co-promotion and co-marketing partnering agreements entered into by the worlds leading biopharma companies. This report provides...
The global protein purification and isolation market exhibited moderate growth during 2015-2020. Looking forward, the analyst expects the market to grow at a CAGR of around 8% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect...
The human microbiome market is projected to reach USD 1,370 million by 2029 from USD 269 million in 2023, at a CAGR of 31.1% from 2023 to 2029. The major factor driving the growth of the human microbiome market is the increasing focus on human microbiome therapy development. The human microbiome as a validated target for drug development &...
253 pages •
By Global Industry Analysts
• Feb 2022
Abstract: What`s New for 2022? -Global competitiveness and key competitor percentage market shares -Market presence across multiple geographies - Strong/Active/Niche/Trivial -Online interactive peer-to-peer collaborative bespoke updates -Access to our digital archives and MarketGlass...
Diagnostics
Chronic Disease
Transportation
Blood Supply
Laboratory
Blood Collection
World
Europe
China
Chronic Disease Prevalence
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.